Clinical Trial Update: A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome [Phase 4]

View source ↗

Summary

This update indicates that the Phase 4 study evaluating Retaine for signs and symptoms of Keratoconjunctivitis Sicca (dry eye) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconjunctivitis Sicca

Drugs mentioned

• Retaine

Snippet

Sponsor: Ocusoft, Inc. | Conditions: Keratoconjunctivitis Sicca | Phase 4 | Status: COMPLETED